Incyte (INCY) FCF Margin (2009 - 2026)
Incyte (INCY) recorded FCF Margin of -44.37% in Q3 2026, down 84.24 percentage points from 39.87% a year earlier and down 73.96 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) FCF Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Incyte's FCF Margin came in at 11.39% as of Sep 30, 2026, down 13.48 percentage points year-over-year; for FY2025, it came in at 26.35%, up 20.48 percentage points from FY2024.
- Annual FCF Margin has a five-year change of +38.05 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at 5.87% in FY2024 (-6.68 pp), 12.56% in FY2023 (-13.72 pp), 26.28% in FY2022 (+7.24 pp) and 19.04% in FY2021 (+30.74 pp).
- The Q3 2026 figure is the lowest quarterly FCF Margin since Q2 2024.
- On a year-over-year basis, FCF Margin rose in seven of the last eight quarters, with an average year-over-year change of +5.42 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 62.44 percentage points in Q2 2025, against a drop of 91.67 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 29.58% (Q2 2026), 28.22% (Q1 2026) and 34.60% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -44.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -44.37% |
| Jun 30, 2026 | 29.58% |
| Mar 31, 2026 | 28.22% |
| Dec 31, 2025 | 34.60% |
| Sep 30, 2025 | 39.87% |
| Jun 30, 2025 | 2.11% |
| Mar 31, 2025 | 24.97% |
| Dec 31, 2024 | 30.87% |
| Sep 30, 2024 | 26.86% |
| Jun 30, 2024 | -60.33% |
| Mar 31, 2024 | 23.76% |
| Dec 31, 2023 | 14.35% |
| Sep 30, 2023 | 14.89% |
| Jun 30, 2023 | 31.34% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | 28.31% |
| Sep 30, 2022 | 32.62% |
| Jun 30, 2022 | 17.82% |
| Mar 31, 2022 | 27.10% |
| Dec 31, 2021 | 9.37% |
API Access
Incyte FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();